Up­dat­ed: Ver­tex un­veils PhI­II plans for non-opi­oid drug fol­low­ing mid-stage suc­cess in pe­riph­er­al neu­ro­path­ic pain

Ver­tex’s non-opi­oid treat­ment can­di­date for acute pain has met the pri­ma­ry end­point of pain re­duc­tion in a Phase II tri­al in di­a­bet­ics with neu­ro­path­ic pain …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER